A prostacyclin receptor antagonist inhibits the sensitized release of substance P from rat sensory neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 315, Issue 3, 2005, Pages 1136-1142

  Nakae, Koichi ^a,b   Saito, Kiyoko ^a   Iino, Takashi ^a   Yamamoto, Noriyuki ^a   Wakabayashi, Mayo ^a   Yoshikawa, Satoru ^a   Matsushima, Satoshi ^a   Miyashita, Hiroshi ^a   Sugimoto, Hiromi ^a   Kiba, Atushi ^a   Gupta, Jung ^a  

^a BAYER YAKUHIN LTD   (Japan)

^b INSTITUTE OF MICROBIAL CHEMISTRY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 PHENOXYMETHYLBENZYLOXYCARBONYLAMINO) 3 PHENYLPROPIONIC ACID; 2 [4 (1H INDOL 4 YLOXYMETHYL)BENZYLOXYCARBONYLAMINO] 3 PHENYLPROPIONIC ACID; BRADYKININ; CARBACYCLIN; CICAPROST; CYCLIC AMP; ICOSANOID; ILOPROST; NEUROTRANSMITTER; PEPTIDE; PROSTACYCLIN RECEPTOR; PROSTACYCLIN RECEPTOR ANTAGONIST; RECEPTOR BLOCKING AGENT; SUBSTANCE P; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CELL CULTURE; CONCENTRATION RESPONSE; DRUG ACTIVITY; NEUROTRANSMITTER RELEASE; NONHUMAN; NONMYELINATED NERVE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SPINAL GANGLION;

ANIMALS; ANTINEOPLASTIC AGENTS; CALCIUM; CELL LINE, TUMOR; CELLS, CULTURED; CHO CELLS; CRICETINAE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GANGLIA, SPINAL; HUMANS; ILOPROST; INHIBITORY CONCENTRATION 50; K562 CELLS; KALLIDIN; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MOLECULAR STRUCTURE; NEURONS, AFFERENT; OSTEOSARCOMA; RATS; RECEPTORS, EPOPROSTENOL; SUBSTANCE P;

EID: 27744480826     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.091967     Document Type: Article

References (39)

1. Abramovitz M, Adam M, Boie Y, Carriere M, Denis D, Godbout C, Lamontagne S, Rochette C, Sawyer N, Tremblay NM, et al. (2000) The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 1483:285-293.
2. Adler JE and Walker PD (2000) Cyclic AMP regulates substance P expression in developing and mature spinal sensory neurons. J Neurosci Res 59:624-631.
3. Anderson KE (1993) Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 45:253-308.
4. Augustine GJ (2001) How does calcium trigger neurotransmitter release? Curr Opin Neurobiol 11:320-326.
5. Bhoola KD, Figueroa CD, and Worthy K (1992) Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol 44:1-80.
6. Bley KR, Hunter JC, Eglen RM, and Smith JA (1998) The role of IP prostanoid receptors in inflammatory pain. Trends Pharmacol Sci 19:141-147.
7. Bombardieri S, Cattani P, Ciabattoni G, Di Munno O, Pasero G, Patrono C, Pinca E, and Pugliese F (1981) The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. Br J Pharmacol 73:893-901.
8. Breyer RM, Bagdassarian CK, Myers SA, and Breyer MD (2001) Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 4:661-691.
9. Bunting S, Moncada S, and Vane JR (1983) The prostacyclin-thromboxane A2 balance: pathophysiological and therapeutic implications. Br Med Bull 39:271-276.
10. Clark RD, Jahangir A, Severance D, Salazar R, Chang T, Chang D, Jett MF, Smith S, and Bley K (2004) Discovery and SAR development of 2-(phenylamino) imidazolines as prostacyclin receptor antagonists. Bioorg Med Chem Lett 14:1053-1056.
11. Cournoyer RL, Keitz PF, Lowrie LE Jr, Muehldorf AV, O'Yang C, and Yasuda DM (2001) inventors, Hoffman-La Roche, assignee. Carboxylic acid derivatives as IP antagonists. WO0168591. 2001 Sep 20.
12. De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, Creminon C, Davis JB, Geppetti P, and Di Marzo V (2001) The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 77:1660-1663.
13. Foletti DL, Blitzer JT, and Scheller RH (2001) Physiological modulation of rabphilin phosphorylation, J Neurosci 21:5473-5483.
14. Hingtgen CM and Vasko MR (1994) Prostacyclin enhances the evoked-release of substance P and calcitonin gene-related peptide from rat sensory neurons. Brain Res 655:51-60.
15. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, et al. (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils and basophils via seventransmembrane receptor CRTH2. J Exp Med 193:255-261.
16. Hoeper MM, Schwarze M, Ehlerding S, Adler-Schuermeyer A, Spiekerkoetter E, Niedermeyer J, Hamm M, and Fabel H (2000) Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med 342:1866-1870.
17. Huang H, Wu X, Nicol GD, Meller S, and Vasko MR (2003) ATP augments peptide release from rat sensory neurons in culture through activation of P2Y receptors. J Pharmacol Exp Ther 306:1137-1144.
18. Khanin M, Liel Y, and Rimon G (1999) Differential effect of TPA on PGE2 and cicaprost-induced cAMP synthesis in UMR-106 cells. Cell Signal 11:165-169.
19. Kopp UC, Cicha MZ, and Smith LA (2002) PGE(2) increases release of substance P from renal sensory nerves by activating the cAMP-PKA transduction cascade. Am J Physiol 282:R1618-R1627.
20. Lee YS, Lee JA, Jung J, Oh U, and Kaang BK (2000) The cAMP-dependent kinase pathway does not sensitize the cloned vanilloid receptor type 1 expressed in xenopus oocytes or Aplysia neurons. Neurosci Lett 288:57-60.
21. Lopshire JC and Nicol GD (1998) The cAMP transduction cascade mediates the prostaglandin E2 enhancement of the capsaicin-elicited current in rat sensory neurons: whole-cell and single-channel studies. J Neurosci 18:6081-6092.
22. Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, Ichikawa A, Aze Y, Tanaka T, Yoshida N, Ueno A, et al. (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature (Lond) 388:678-682.
23. Murray R, Furci L, and FitzGerald GA (1989) Induction of prostacyclin receptor expression in human erythroleukemia cells. FEBS Lett 255:172-174.
24. Nakatsuka T, Mena N, Ling J, and Gu JG (2001) Depletion of substance P from rat primary sensory neurons by ATP, an implication of P2X receptor-mediated release of substance P. Neuroscience 107:293-300.
25. Oberpenning F, van Ophoven A, and Hertle L (2002) Interstitial cystitis: an update. Curr Opin Urol 12:321-332.
26. Oida H, Namba T, Sugimoto Y, Ushikubi F, Ohishi H, Ichikawa A, and Narumiya S (1995) In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br J Pharmacol 116:2828-2837.
27. Parfenova H, Hsu P, and Leffler CW (1995) Dilator prostanoid-induced cyclic AMP formation and release by cerebral microvascular smooth muscle cells: inhibition by indomethacin. J Pharmacol Exp Ther 272:44-52.
28. Pitchford S and Levine JD (1991) Prostaglandins sensitize nociceptors in cell culture. Neurosci Lett 132:105-108.
29. Proud D and Kaplan AP (1988) Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol 6:49-83.
30. Rathee PK, Distler C, Obreja O, Neuhuber W, Wang GK, Wang SY, Nau C, and Kress M (2002) PKA/AKAP/VR-1 module: a common link of Gs-mediated signaling to thermal hyperalgesia. J Neurosci 22:4740-4745.
31. Samad TA, Sapirstein A, and Woolf CJ (2002) Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets, Trends Mol Med 8:390-396.
32. Sant GR and Theoharides TC (1999) Interstitial cystitis. Curr Opin Urol 9:297-302.
33. Schwaner I, Offermanns S, Spicher K, Seifert R, and Schultz G (1995) Differential activation of Gi and Gs proteins by E- and I-type prostaglandins in membranes from the human erythroleukaemia cell line, HEL. Biochim Biophys Acta 1265:8-14.
34. Smith JA, Amagasu SM, Eglen RM, Hunter JC, and Bley KR (1998) Characterization of prostanoid receptor-evoked responses in rat sensory neurones. Br J Pharmacol 124:513-523.
35. Smith JA, Davis CL, and Burgess GM (2000) Prostaglandin E2-induced sensitization of bradykinin-evoked responses in rat dorsal root ganglion neurons is mediated by cAMP-dependent protein kinase A. Eur J Neurosci 12:3250-3258.
36. Taiwo YO, Bjerknes LK, Goetzl EJ, and Levine JD (1989) Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience 32:577-580.
37. Vane JR and Botting RM (1995) Pharmacodynamic profile of prostacyclin. Am J Cardiol 75:3A-10A.
38. White DM (1997) Release of substance P from peripheral sensory nerve terminals. J Peripher Nerv Syst 2:191-201.
39. Yoshimura N, Seki S, Chancellor MB, de Groat WC, and Ueda T (2002) Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology 59:61-67.